A Study to Assess Safety, Tolerability and Pharmacokinetics of of AZD6553 in Healthy Volunteers and Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE1TerminatedINTERVENTIONAL

Enrollment

109

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

AZD6553

Single or multiple oral dose

DRUG

Placebo

single or multiple oral dose

Trial Locations (1)

Research Site, London